These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 38831979)

  • 1. MAL2 DNA methylation serves as a biomarker for the diagnosis and prognosis of glioma.
    Luo H; Xiao X; Hou W; Cai J; Chen M; Tang Q; Tong Y; Qi Z; Li K; Chen L
    Genes Dis; 2024 Sep; 11(5):101082. PubMed ID: 38831979
    [No Abstract]   [Full Text] [Related]  

  • 2. Alu methylation serves as a biomarker for non-invasive diagnosis of glioma.
    Chen J; Huan W; Zuo H; Zhao L; Huang C; Liu X; Hou S; Qi J; Shi W
    Oncotarget; 2016 May; 7(18):26099-106. PubMed ID: 27028997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of MAL2 Correlates with Immune Infiltration and Poor Prognosis in Breast Cancer.
    Zhong Y; Zhuang Z; Mo P; Shang Q; Lin M; Gong J; Huang J; Mo H; Huang M
    Evid Based Complement Alternat Med; 2021; 2021():5557873. PubMed ID: 34567213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitive Detection and Conjoint Analysis of Promoter Methylation by Conjugated Polymers for Differential Diagnosis and Prognosis of Glioma.
    Ma L; Huang Y; Zhang H; Ning W; Qi R; Yuan H; Lv F; Liu L; Yu C; Wang S
    ACS Appl Mater Interfaces; 2021 Mar; 13(8):9291-9299. PubMed ID: 32436715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dimethylation of histone H3 lysine 36 (H3K36me2) as a potential biomarker for glioma diagnosis, grading, and prognosis.
    Cong H; Guo X; Fan B; Liu Y; Dong C; Sui A
    J Neuropathol Exp Neurol; 2023 Apr; 82(5):412-418. PubMed ID: 36921281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The four-transmembrane protein MAL2 and tumor protein D52 (TPD52) are highly expressed in colorectal cancer and correlated with poor prognosis.
    Li J; Li Y; Liu H; Liu Y; Cui B
    PLoS One; 2017; 12(5):e0178515. PubMed ID: 28562687
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Noor H; Zaman A; Teo C; Sughrue ME
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MAL2 interacts with IQGAP1 to promote pancreatic cancer progression by increasing ERK1/2 phosphorylation.
    Zhang B; Xiao J; Cheng X; Liu T
    Biochem Biophys Res Commun; 2021 May; 554():63-70. PubMed ID: 33780861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cell differentiation protein 2 facilitates cell proliferation by enhancing mTOR-mediated ribosome biogenesis in non-small cell lung cancer.
    Lian Z; Yan X; Diao Y; Cui D; Liu H
    Discov Oncol; 2022 Apr; 13(1):26. PubMed ID: 35437691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LRRFIP1, an epigenetically regulated gene, is a prognostic biomarker and predicts malignant phenotypes of glioma.
    Ma W; Bao Z; Qian Z; Zhang K; Fan W; Xu J; Ren C; Zhang Y; Jiang T
    CNS Neurosci Ther; 2022 Jun; 28(6):873-883. PubMed ID: 35338570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MAL2 and tumor protein D52 (TPD52) are frequently overexpressed in ovarian carcinoma, but differentially associated with histological subtype and patient outcome.
    Byrne JA; Maleki S; Hardy JR; Gloss BS; Murali R; Scurry JP; Fanayan S; Emmanuel C; Hacker NF; Sutherland RL; Defazio A; O'Brien PM
    BMC Cancer; 2010 Sep; 10():497. PubMed ID: 20846453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of MAL2 inhibits breast cancer progression through regulating β-catenin/c-Myc axis.
    An L; Gong H; Yu X; Zhang W; Liu X; Yang X; Shu L; Liu J; Yang L
    Cancer Cell Int; 2023 Jul; 23(1):144. PubMed ID: 37480012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Advances of glioma biomarkers].
    Hao M; Liang Y; Guo R; Li X; Li Y; Wang L; Yu C; Yang Z
    Sheng Wu Gong Cheng Xue Bao; 2023 Apr; 39(4):1445-1461. PubMed ID: 37154316
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Wang Z; Jiang W; Wang Y; Guo Y; Cong Z; DU F; Song B
    Biomed Rep; 2015 Jul; 3(4):543-548. PubMed ID: 26171163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic significance of suppressor of cytokine signalling 3 (SOCS3) methylation and its correlation with IDH1 mutation in Chinese glioma patients.
    Jiao W; Xun X; Liu J; Yang J; Wang Q; Wang L; Chen C; Wang H; Dai P
    Biomarkers; 2016 Dec; 21(8):686-691. PubMed ID: 27441955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myelin and lymphocyte protein 2 regulates cell proliferation and metastasis through the Notch pathway in prostate adenocarcinoma.
    Zheng C; Wang J; Zhang J; Hou S; Zheng Y; Wang Q
    Transl Androl Urol; 2021 May; 10(5):2067-2077. PubMed ID: 34159087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective increase in subtelomeric DNA methylation: an epigenetic biomarker for malignant glioma.
    Choudhury SR; Cui Y; Milton JR; Li J; Irudayaraj J
    Clin Epigenetics; 2015; 7():107. PubMed ID: 26451167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA methylation heterogeneity attributable to a complex tumor immune microenvironment prompts prognostic risk in glioma.
    Ma S; Pan X; Gan J; Guo X; He J; Hu H; Wang Y; Ning S; Zhi H
    Epigenetics; 2024 Dec; 19(1):2318506. PubMed ID: 38439715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoter hypermethylation-mediated inactivation of LRRC4 in gliomas.
    Zhang Z; Li D; Wu M; Xiang B; Wang L; Zhou M; Chen P; Li X; Shen S; Li G
    BMC Mol Biol; 2008 Nov; 9():99. PubMed ID: 18976507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Significance of mRNA Expression RBBP8 or Its Methylation in Gliomas.
    Liu Z; Cheng X; Lin S; Han Z; Jin H; Luan Z; Li P; Liang W; Qian R; Gao Y
    Cell Mol Neurobiol; 2023 Jan; 43(1):409-422. PubMed ID: 35106666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.